RisingCOA VerifiedInjectable
Cagrilintide
Long-acting amylin analogue researched in combination with GLP-1 agonists
Half-life
~7 days
Typical Dose
0.3-2.4mg weekly
Format
Injectable
Purity
≥98%
Overview
Cagrilintide is a long-acting amylin analogue. When combined with Semaglutide (CagriSema), it produces enhanced weight reduction effects beyond Semaglutide alone.
Mechanism
Amylin receptor agonist that complements GLP-1 mechanisms. Amylin slows gastric emptying and increases satiety through different pathways than GLP-1.
Researched benefits
- Synergistic with GLP-1 agonists
- Reduced food cravings
- Improved satiety
- Once-weekly dosing
Ready to start your research
Get Cagrilintide from Ascension Peptides
COA-verified, US-based, discreet shipping. Use code ENHANCED for 50% off your entire order.
Buy Cagrilintide now